Table 1.
Trophoblasts | Leukocytes | NRBCs | HSCs | MSCs | PAPCs | |
---|---|---|---|---|---|---|
Specific cell markers | No, although HLA-G has potential | Yes | Yes, improving with use of embryonic hemoglobins | Yes | Yes, although defined by absence of markers | CD34+CD38+Endothelial |
Similarity to maternal cells | None | Yes | Yes, with exception of primitive fetal NRBCs | Yes, but have higher proliferative potential | None in blood | Not known |
Found in non-pregnant adult circulation | No, cleared by pulmonary circulation | Yes | Yes | Not typically | No | No |
Persist in maternal tissues | No | Yes | No, short-lived | Yes | Yes | Yes |
Other qualities | Developmentally end-stage, Multinucleated |
Identified by HLA differences between mother and fetus | Physiologic increase in maternal NRBCs occurs during pregnancy | Rare, but can be amplified in vitro | Rare, but can be amplified in vitro, may escape immune rejection. Likely to adhere and engraft rapidly |
Have capability of differentiation to repair maternal tissues |
Abbreviations: NRBCs, nucleated erythrocytes; HSCs, hematopoietic stem cells; MSCs, mesenchymal stem cells; PAPCs, pregnancy-associated progenitor cells; HLA, human leukocyte antigen.